Is Tandem Diabetes Care (TNDM) Still Undervalued After Its Recent Share Price Rebound? [Yahoo! Finance]
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Yahoo! Finance
See our latest analysis for Tandem Diabetes Care. That rebound reflects a shift in sentiment, with the strong 90 day share price return of 87.33% coming after a rough stretch that left the year to date share price return at negative 37.28% and the 1 year total shareholder return at negative 39.05%. This suggests momentum is rebuilding from a low base. If Tandem's turnaround has your attention, this could be a good moment to explore other medical names using our healthcare stocks screener healthcare stocks for new ideas. With modest revenue growth, improving earnings and shares still trading below analysts' targets, investors now face a key question: is Tandem genuinely undervalued after a brutal multi year slide, or is the market already pricing in a full recovery? With Tandem Diabetes Care last closing at $22.48 against a most popular narrative fair value of $20.64, the story leans toward optimism with a premium. The analysts have a consensus price target of $22.619 for Ta
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- What Tandem Diabetes Care (TNDM)'s Canadian Smartphone Bolus Launch Means For Shareholders [Yahoo! Finance]Yahoo! Finance
- Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDMPR Newswire
- Clinical ink announces collaboration with Tandem Diabetes Care to integrate Automated Insulin Delivery data into the GlucoseReady™ connected device software platformPR Web
- TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire
- Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks [Yahoo! Finance]Yahoo! Finance
TNDM
Earnings
- 11/6/25 - In-Line
TNDM
Sec Filings
- 12/17/25 - Form 4
- 12/17/25 - Form 4
- 12/8/25 - Form 4
- TNDM's page on the SEC website